Evidence-based recommendations on the Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain
Evidence-based recommendations on Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers
Evidence-based recommendations on iFuse titanium implant joint fusion system for treating chronic sacroiliac (SI) joint pain (lower back pain)
Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta
Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury
In development [GID-DG10033] Expected publication date: 29 July 2020
In development [GID-DG10034] Expected publication date: 30 September 2020
In development [GID-DG10035] Expected publication date: 26 August 2020
We are listening to your views on this diagnostics guidance. Comments close 04 February 2020.
In development [GID-DG10029] Expected publication date: 26 August 2020
In development [GID-DG10023] Expected publication date: 27 May 2020
In development [GID-DG10028] Expected publication date: 22 April 2020
In development [GID-MT536] Expected publication date: TBC
In development [GID-MT533] Expected publication date: 06 July 2020
In development [GID-MT532] Expected publication date: TBC
In development [GID-MT531] Expected publication date: TBC
In development [GID-MT534] Expected publication date: TBC
In development [GID-MT526] Expected publication date: TBC
In development [GID-MT538] Expected publication date: TBC
In development [GID-MT527] Expected publication date: 30 January 2020
In development [GID-MT537] Expected publication date: 21 December 2020
In development [GID-MT543] Expected publication date: 06 October 2020
In development [GID-MT544] Expected publication date: 15 September 2020
In development [GID-MT529] Expected publication date: 06 April 2020
In development [GID-MT528] Expected publication date: 27 March 2020
This guidance has been updated and replaced by NICE guideline NG47.
In development [GID-DT9] Expected publication date: TBC
In development [GID-DT14] Expected publication date: TBC
In development [GID-DT28] Expected publication date: TBC
Both index tests included in this guidance are no longer commercially available. Therefore the guidance has been withdrawn.
This guideline has been updated and replaced by NICE guideline NG131.
This guidance has been updated and replaced by NICE diagnostics guidance 34.
This guidance has been updated and replaced by NICE diagnostics guidance 32.
In development [GID-TA10342] Expected publication date: 01 July 2020
In development [GID-TA10119] Expected publication date: 01 July 2020
In development [GID-MT267] Expected publication date: TBC
In development [GID-MT163] Expected publication date: TBC
In development [GID-MT81] Expected publication date: TBC
In development [GID-MT516] Expected publication date: TBC
In development [GID-MT517] Expected publication date: TBC
In development [GID-MT130] Expected publication date: TBC
In development [GID-MT117] Expected publication date: TBC
In development [GID-MT510] Expected publication date: TBC
In March 2019, NICE reviewed this guidance and recommended it should be withdrawn because Vision Amniotic Leak Detector is no longer available. NICE has produced a medtech innovation briefing on AmnioSense for unexplained vaginal wetness in pregnancy. For a copy of the review decision, please contact nice@nice.org.uk.
In March 2018, NICE reviewed this guidance and recommended it should be withdrawn as it has been updated and replaced by the NICE guideline on hypothermia: prevention and management in adults having surgery (NICE guideline CG65, updated 2016). For a copy of the review decision please contact nice@nice.org.uk.
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
In development [GID-TA10331] Expected publication date: 01 April 2020
In development [GID-TA10323] Expected publication date: 01 April 2020
Evidence-based recommendations on trametinib (Mekinist) with dabrafenib (Tafinlar) for treating unresectable or metastatic melanoma with a BRAF V600 mutation
Evidence-based recommendations on evolocumab (Repatha) for treating primary hypercholesterolaemia (high cholesterol) and mixed dyslipidaemia